A. Bang

发表

A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.

Emily M. Thrash, R. Mak, R. Tishler, 2020, International journal of radiation oncology, biology, physics.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Cyclosporine I.V. Dose Adjustment in Patients with Hematopoietic Stem Cell Transplantation

Eun Sook Lee, A. Bang, Euni Lee, 2016 .

Immunotherapy and radiotherapy for metastatic cancers.

A. Bang, J. Schoenfeld, 2019, Annals of palliative medicine.

Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated with Anti-PD-1 Therapy

P. Ott, A. Spektor, M. Awad, 2018, International Journal of Radiation Oncology, Biology, Physics.

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.

F. Hodi, B. Mahal, B. Alexander, 2019, International journal of radiation oncology, biology, physics.

PACIFIC: shifting tides in the treatment of locally advanced non-small cell lung cancer.

A. Sun, A. Bang, J. Schoenfeld, 2019, Translational lung cancer research.

A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.

Emily M. Thrash, R. Mak, R. Tishler, 2019, International journal of radiation oncology, biology, physics.

Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.

W. Kendal, A. Bang, S. Laurie, 2018, International journal of radiation oncology, biology, physics.

Combined Radiotherapy and New Systemic Therapies - Have We Moved Beyond Palliation?

K. Fife, A. Bang, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysis

A. Bang, M. Tjong, M. Kucharczyk, 2022, Oncotarget.

Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers

J. Pantarotto, S. Gilbert, A. Bang, 2019, Clinical and translational radiation oncology.

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2022, JAMA oncology.

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors

A. Bang, J. Schoenfeld, Jungwook Shin, 2021, Advances in radiation oncology.

Validation of the prognostic utility of ESTRO/EORTC oligometastatic disease classification: a secondary analysis from the population-based phase II SABR-5 trial.

N. Chng, S. Tyldesley, R. Olson, 2022, International journal of radiation oncology, biology, physics.

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation.

P. Catalano, F. Hodi, B. Alexander, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.

F. Hodi, P. Ott, A. Spektor, 2017, International journal of radiation oncology, biology, physics.

Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy

P. Ott, A. Spektor, M. Awad, 2019, Frontiers in oncology.

Radiotherapy for HCC: Ready for prime time?

L. Dawson, A. Bang, 2019, JHEP reports.

Stereotactic body radiotherapy for centrally located stage I non-small cell lung cancer.

A. Bezjak, A. Bang, 2018, Translational lung cancer research.

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictors of early polymetastatic relapse following stereotactic ablative radiotherapy for up to 5 oligometastases: a secondary analysis of the phase II SABR-5 trial.

N. Chng, S. Tyldesley, Mengxing Liu, 2022, International journal of radiation oncology, biology, physics.

Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated With Anti-PD-1 Therapy

P. Ott, A. Spektor, M. Awad, 2019, Front. Oncol..

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.